Sangamo Therapeutics
Richmond, CA
Sangamo Therapeutics, Inc. is focused on translating groundbreaking science into genomic therapies that transform patients' lives. The company leverages industry-leading platform technologies in genome editing, gene therapy, gene regulation, and cell therapy to address complex diseases.
Sangamo is advancing clinical programs targeting conditions such as hemophilia A, Fabry disease, hemoglobinopathies, and renal transplant, with the goal of delivering treatments that go beyond symptom management to provide meaningful, long-term outcomes for patients.
Pan-Pacific Mechanical is responsible for the plumbing, HVAC, and process piping scopes on this project, supporting the specialized infrastructure required for advanced biopharmaceutical research and development.